Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States
- 1 January 2007
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 119 (1), e12-e21
- https://doi.org/10.1542/peds.2006-1573
Abstract
OBJECTIVES. Economic analysis is an important component in formulating national policy. We evaluated the economic impact of hepatitis A vaccination of all US children ages 12 to 23 months as compared with no vaccination and with current implementation of the preexisting (issued in 1999), regional policy.Keywords
This publication has 26 references indexed in Scilit:
- The Economics of Routine Childhood Hepatitis A Immunization in the United States: The Impact of Herd ImmunityPublished by American Academy of Pediatrics (AAP) ,2007
- Pertussis in Adolescents and Adults: Should We Vaccinate?Published by American Academy of Pediatrics (AAP) ,2005
- Regional variation in the cost effectiveness of childhood hepatitis A immunizationThe Pediatric Infectious Disease Journal, 2003
- Valuation of Symptomatic Hepatitis A in AdultsPharmacoEconomics, 2002
- Health Utility Attributes for Chronic ConditionsDisease Management and Health Outcomes, 2001
- The cost of hepatitis A infections in American adolescents and adults in 1997Hepatology, 2000
- Cost-effectiveness analysis of hepatitis A vaccination strategies for adultsHepatology, 1999
- Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendationsPublished by American Medical Association (AMA) ,1995
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis AVaccine, 1993